Burkholderia cepacia is an opportunistic pathogen causing infections in patients with cystic fibrosis. Patients with implanted devices are prone to B. cepacia infections due to its ability to grow as biofilms. Knowing the importance of polysaccharides in a biofilm, enzymes that degrade them were targeted as a possible candidate for antibiofilm agents. In this study, the antibio lm potential of cellulase against B. cepacia biofilms formed on various prosthetic materials was tested. Cellulase exhibited signi cant antibio lm activity against B. cepacia without having much action on its growth, thus ruling out the chance of selection pressure and subsequent development resistance.
Burkholderia cepacia is an imperative pathogen known to accentuate the pathogenesis of cystic fibrosis (CF) and chronic granulomatous diseases in immunocompromised individuals. e opportunistic human pathogen, grouped under B. cepacia complex (BCC) is frequently retrieved from CF patients (McDowell et al., 2001 ). e B. cepacia infections predominantly result in asymptomatic carriage, gradual decline in lung function and cepacia syndrome, a terminal necrotizing pneumonia (Vandamme, 2001 ). e sternness of these infections in immunocompromised hosts is attributed to the organism's diverse virulence factors and the ability to form biofilms. B. cepacia secretes numerous virulence factors viz. lipase, metalloproteases, serine proteases, which intensify the pathogenic traits via cep quorum sensing system (Shawn et al., 1999) . B. cepacia is also known to produce exopolysaccharide cepacian that reinforce the biofilm integrity (Monica et al., 2004) . e bacteria within the biofilm consortium are highly resistant to standard antibiotics. e innate and emerging resistance of biofilm residing bacteria against antibiotics in the current scenario consequently lead to the screening of various alternative sources to eradicate the bacterial pathogen (Jones et al., 2004) . Cellulase cleaves the β-1,4 linkages in exopolysaccharides, a major constituent of biofilms. Studies on the use of cellulase to inhibit biofilm have been reported and describe partial inhibition of Pseudomonas aeruginosa biofilms (Melanie et al., 2003) . Other studies have reported the accumulation of BCC on various contaminated pharmaceuticals and cosmetics (Sousa et al., 2011) . Hence, the present study has focused on inhibition of B. cepacia biofilms on prosthetic materials like poly -styrene, polyvinyl, polycarbonate and glass surfaces using cellulase enzyme.
Reference strains of B. cepacia (MTCC-1617, 6902 and 438) and B. cepacia (EU053863.1) were initially used and later the strain 1617 was used for all the assays due to its clinical origin and superior biofilm forming ability. Cellulase from Aspergillus niger (C1184-SigmaAldrich) and partially purified cellulase from Bacillus sp. DGV19 (EU053862.1) were used for quantitative biofilm inhibition assays. A fixed concentration of cellulase (100 units ml ) was used for all the analysis. Cellulase production in cell free supernatant (CFS) of Bacillus sp. DGV19 was phenotypically confirmed by carboxymethyl cellulose clear zone (CMCZ) test and by the indication of an evident 76 kDa protein band in SDS-PAGE gel stained with comassive brilliant blue (CBB R250). For biofilm assays, sterile disks of 10 mm diameters of polystyrene (Tarsons Product Pvt. Ltd., India), glass slides, polyvinyl chloride (PVC) and polycarbonate (Himedia., India) were place on the bottom of a 24-well microtiter plate. e 100 µl of the enzyme was added to nutrient broth supplemented with 0.5% glucose containing the bacterial suspension at 10 6 CFU ml -1 and incubated at 37°C for 24 hours. Following incubation, the plates were washed with distilled water to remove the unbound bacterial cells and the biofilm was stained with 0.4% crystal violet. e substrates were destained with 95% ethanol and biofilm density was quantified at 575 nm using UV spectrophotometer (Bakkiyaraj et al., 2010) . e bacteriostatic e ect of cellulase in broth cultures were quantitatively measured at 600 nm. Similar sets of experiments were conducted with CFS of Bacillus sp. DGV19. All the experiments were done in triplicates and the statistical analyses were executed using SPSS. Values were expressed as mean ± SD and the statistical significance was analyzed by student's t-test. e percentage of biofilm inhibition was estimated by the following formula; % biofilms inhibition = ([control OD 575 nm -test OD 575 nm]/ control OD 575 nm) x 100.
Cellulase had no e ect on the growth of B. cepacia (Fig. 1a) , but showed significant reduction of biofilms on various materials tested (P < 0.05) (Fig. 1b) . e biofilms on various substrates were initially examined with a light microscope and further qualitatively confirmed using a confocal laser scanning microscope (CLSM) (Zeiss/LSM 710, Carl Zeiss, Germany) a er subsequent staining with 0.01% acridine orange (Bakkiyaraj et al., 2012) . Focus stacking was executed using Zen 2009 so ware. Maximum biofilm production and subsequent inhibition by cellulase/CFS was visualized in polystyrene surfaces when compared to the other substrates (Fig. 2a) . e 3-dimensional CLSM images showed considerable reduction in B. cepacia biofilm density and thickness when treated with cellulase (Fig. 3) . Focus stacking revealed approximately 50% diminution of biofilms formed by B. cepacia on various substrates tested. Maximum inhibition was eminent in polystyrene surfaces with 68%, followed by 57% on glass. 50% inhibition was observed on PVC and polycarbonate surfaces respectively. e CFS from Bacillus sp. DGV19 produced cellulase, which possessed antibiofilm activity against the opportunistic pathogen. e inhibition of B. cepacia biofilms by CFS was not exclusively due to the enzymatic activity of cellulase, as Bacillus sp. DGV19 was also shown to possess quorum quenching (QQ) activity against the indicator strain, Chromobacterium violaceum ATCC12472. e presence of aiiA homologue gene, encoding N-Acyl-homoserine lactonase in Bacillus sp. DGV19 was confirmed by PCR amplification using forward (5' ATGGGATCCATGA-CAGTAAAGAAGCTTTAT-3') and reverse (5'-GTC-GAATTCCTCAACAAGATACTCCTAATG-3') primers (Fig. 2b) .
In conclusion, the results of the present study apparently manifest the ability of cellulase to marginally inhibit B. cepacia biofilms grown on various prosthetic materials. It has also been demonstrated that the cellulase does not inhibit the growth of the bacteria while controlling its biofilm formation on di erent substrates.
e plausible mechanism of biofilm inhibition may involve the degradation of exopolysaccharide cepacian by the cellulase. Further study is warranted for implementing the enzyme treatment in combination with other anti-quorum sensing agents/enzymes for absolute inhibition of B. cepacia biofilms on clinical devices. 
